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In mammals, platelets are small, anucleate circulating elements 
best known for their capacity to rapidly aggregate and pre-
vent blood loss during trauma. In the 19th century, the vi-
sionary pioneers Schulze and Bizzozero were rapidly drawn 
to the study of platelets in hemostasis given the efficiency 
and prominence of the process. Decades of continued stud-
ies have identified many of the components and mechanisms 
that make platelets so sensitive to stimulation but, at the same 
time, have recognized the many ways in which their uncon-
trolled activation compromises vascular integrity, as seen in 
several of the most prevalent and deadly syndromes, from 
strokes and heart attacks to venous thromboses. These early 
studies found comforting consistency between the “passive” 
formation of blood clots and the lack of “transcriptional in-
telligence” in platelets.
Many decades after these observations were made, how-
ever, researchers began to notice striking correlations be-
tween platelet numbers and activation states with the onset 
of immune and inflammatory responses. Further studies dis-
covered that platelet contribution extends to angiogenic and 
developmental processes, to the direct killing of microorgan-
isms, and even to tumor metastasis. Thus, although hemostasis 
remains their best characterized function, we now know that 
platelets are used for many additional tasks in the organism. It 
follows that the vast array of proteins and transcriptional and 
translational machinery left within them might have largely 
unknown purposes. In this review, we focus on the seem-
ingly contradictory well-orchestrated, multitasking functions 
of platelets and their lack of regulated transcription. We dis-
cuss here aspects of platelet biology not usually described in 
textbooks and other recent reviews, specifically how plate-
lets appear to be designed for their hemostatic and immune 
functions. We argue that platelets may be best conceived 
as automated, fully equipped vehicles in which trade-offs 
were made during evolution to enhance their surveillance 
and effector functions.
Analogy between platelets and drones
Platelet evolution in mammals and equivalents in other ver-
tebrates. In lower vertebrates such as birds, reptiles, amphibi-
ans, and fish, hemostatic functions are generally performed by 
large, nucleated thrombocytes (Claver and Quaglia, 2009) that 
also carry out important immune processes such as phagocy-
tosis (Nagasawa et al., 2014). These cells are widely regarded 
as the functional equivalents of mammalian platelets and may 
be evolutionarily related. Even in nonvertebrate arthropods, 
coagulation usually involves nucleated cells (e.g., coagulocytes 
in insects; Theopold et al., 2004). The most obvious morpho-
logical difference between the mammalian platelet and the 
nonmammalian thrombocyte is the lack of a nucleus in the 
platelet. As we have learned from textbooks, the eukaryotic 
cell, as opposed to the prokaryote, is defined largely by the 
presence of the genome-containing nucleus that directs the 
whole organization of the cell. Thus, the lack of a nucleus in 
the platelet, together with other factors, such as its humble 
size and production method, has led to controversy over its 
formal recognition as a cell (Garraud and Cognasse, 2015). 
Although platelets have traditionally been termed “cell frag-
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ments,” which misleadingly implies a passivity and nonliving 
status, they are now increasingly referred to as “anucleate cells.”
As we shall discuss later, the absence of the nucleus 
in the platelet is a profound change that accords novel ad-
vantageous capabilities in a trade-off against the associated 
disadvantages. For the purpose of our discussion, it might be 
instructive to compare platelets with another cell type that 
has not attracted as much controversy: the hemoglobin-rich, 
oxygen-carrying erythrocyte. Although we may be used to 
thinking that erythrocytes eventually extrude their nuclei 
upon maturity (i.e., enucleation) on the basis of our under-
standing of mammalian biology, this is actually not the case 
for all species. In fact, most nonmammals retain nucleated 
erythrocytes, and enucleated erythrocytes are the exceptions 
rather than the rule. Despite this, among the salamander 
family Plethodontidae, a few interesting species were dis-
covered to possess enucleated erythrocytes, whereas the oth-
ers retained nuclei in their erythrocytes. The commonalities 
shared by these salamanders with enucleated erythrocytes 
were their larger genome sizes and greatly reduced body 
sizes, relative to the other salamanders. Phylogenetic com-
parisons among various salamander species demonstrated 
positive direct correlations among genome size, nucleus size, 
and erythrocyte cell size in both enucleated and nucleated 
species (Mueller et al., 2008). Therefore, it appeared that the 
greater the DNA content, the more space the nuclei had to 
occupy, and the larger the erythrocytes had to be. From this 
study, a logical conjecture was that getting rid of the bulky 
nucleus afforded the salamander erythrocytes an evolution-
ary advantage in maneuverability, consistent with the selec-
tion pressures on these salamanders toward petite body sizes.
Interesting insights on platelet design can be drawn by 
comparing the clotting efficiency among different species, for 
example, between birds and mammals (Schmaier et al., 2011). 
Although thrombotic cardiovascular diseases such as stroke 
and heart attacks occur often in humans and can be experi-
mentally induced in mammals, birds have not been reported 
to suffer from the same. Schmaier et al. (2011) found that 
although both platelets in mice and thrombocytes in birds 
reacted similarly to activating stimuli, thrombocytes were 
less efficient in spreading on collagen surfaces and expressed 
fewer adhesion molecules on their surfaces, and the aggregates 
formed were unable to resist the shear forces of arterial blood. 
Consequently, birds do not form arterial thromboses but may 
be less efficient at hemostasis than mammals. On the other 
hand, in lower arthropods such as insects, which have virtually 
zero risk for thrombosis thanks to their open hemolymph 
systems (i.e., tissues are directly in contact with hemolymph), 
enzymatic hemostasis mechanisms, analogous to mammalian 
thrombin-fibrin cascades, create aggregates that are directly 
held by strong covalent bonds, unlike the comparatively weak 
protein-protein interactions in vertebrates (Theopold et al., 
2004). Thus, platelet design may be influenced by the differ-
ing selection pressures in the different clades, with the mam-
mals favoring effective hemostasis over thrombosis risks.
Design similarities with unmanned aerial vehicles (UAVs). A 
popular adage in biology is that “form follows function.” 
From our previous erythrocyte example, it would seem that 
removing nuclei from cells that do not require full access to 
the genome for their functions is efficient and logical. How-
ever, platelets perform functions much more complex than 
erythrocytes and, as we describe below, appear to have many 
similarities with human-engineered UAVs, or “drones” in 
common parlance (see Table 1).
Trade-offs associated with platelet design. In a similar fash-
ion to the UAV concept, nuclei removal allows platelets to 
reach sizes much smaller than traditional cells, which grants 
considerable gains to their expendability and maneuverability. 
However, a secondary outcome of their humble size is that 
platelets forgo much of their phagocytic ability, a capability 
robustly demonstrated by thrombocytes but now mostly 
taken over by other larger specialized leukocytes. Platelets 
have high surface-to-volume ratios by virtue of their small 
sizes, and this ratio is increased even further by their adoption 
of the unique open canaliculi system (OCS), in which their 
surface membranes invaginate extensively inward into the 
platelet body, taking full advantage of the lack of central nu-
clei. These form a network of narrow channels whereby cell 
membranes come into contact with the blood plasma, thereby 
providing a large surface area for platelets to interact with 
their environment. Attempts to engulf cells or particles larger 
than themselves are unlikely to be effective, and although 
possible (e.g., bacteria), the amount of cytoplasm available for 
the phagolysosome formation would be very limited. A mea-
sure of “phagocytic” ability is retained, however, as platelets 
have been shown to unfold their OCS to incompletely wrap 
and immobilize bacteria (White, 2005).
A downside of platelets’ lacking nuclei is their reduced 
autonomy, as having access to the full genome may have 
been beneficial in certain situations. For example, because 
platelets contain ribosomes and are fully capable of trans-
lating mRNA, they can become highly attractive targets of 
infection by viruses, especially single-stranded RNA viruses 
that do not require DNA in their reproduction cycle. The 
classic antiviral type I interferon responses, which are acti-
vated largely at the transcription factor level in the nucleus, 
are unavailable to platelets. In fact, it was shown that the 
dengue virus, a well-known single-stranded RNA virus of 
the Flaviviridae family, can actively infect platelets and hi-
jack their machinery to produce fully active virions (Simon 
et al., 2015). In this case, the only reasonable defense may 
be to halt platelet production altogether: megakaryocytes 
greatly reduce platelet production in response to type I in-
terferons, leading to thrombocytopenia (Wadenvik et al., 
1991; Rivadeneyra et al., 2015). It is perhaps no coinci-
dence, then, that the dengue virus is notorious for its ability 
to cause the dreaded life-threatening dengue hemorrhagic 
fever, in which bleeding and blood plasma leakage accom-
pany extreme thrombocytopenia.
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Other than the obvious reductions in energy and ma-
terial production costs attributed directly to forgoing the 
nuclei, another major reason why platelets become so cost 
effective lies in their production mechanism. Megakaryocytes 
in the bone marrow undergo multiple rounds of programmed 
endomitosis, eventually forming large polyploid cells (4N to 
64N; Foudi et al., 2014) about 50–100 µm in diameter, fol-
lowed by the mass production of platelet components in the 
cytoplasm. This process avoids the expensive energy costs as-
sociated with nuclei segregation and occurs rarely in adult 
mammals, although hepatocytes and certain muscle cell types 
also undergo polyploidy at some point in their lifespan (Zim-
met and Ravid, 2000). Megakaryocytes then form cytoplas-
mic extensions (termed proplatelets) that extend through the 
bone marrow into the sinusoids, and directed microtubule 
transport allocates platelet proteins into the tips to form cyto-
plasm fragments like “beads on a chain” that eventually break 
off to form individual preplatelets (Machlus and Italiano, 
2013). Finally, preplatelets fragment further in the circulation 
to form individual platelets. This platelet production strategy 
in megakaryocytes is made possible only because nuclei have 
been omitted from the platelet design, allowing very large 
numbers of individual platelets to be produced rapidly and ef-
ficiently; a single microliter of blood typically contains at least 
a few hundred thousand platelets, with the turnover rate es-
timated at 1011 per day in humans. Interestingly, the demands 
of the process seem to be relatively flexible, as recent work 
demonstrated that part of this process also occurs in the lung 
(accounting for up to 50% of total daily platelet turnover; 
Lefrançais et al., 2017).
Environmental and danger sensing by platelets
Platelets as surveillance drones. Their ubiquity and high ma-
neuverability enable platelets to obtain virtually full coverage 
Table 1. Similarities between the UAV and the platelet
UAV Platelet
Definition
Militarya: “A powered, aerial vehicle that does not carry a human operator, uses 
aerodynamic forces to provide vehicle lift, can fly autonomously or be piloted 
remotely, can be expendable or recoverable, and can carry a lethal or nonlethal 
payload.”b
Medicalc: “A minute, non-nucleated, disk-like cytoplasmic body found in the blood 
plasma of mammals that is derived from a megakaryocyte and functions to promote 
blood clotting.”d
Overall autonomy
Physical location of “intelligence”
Does not carry a human operator.e Does not contain a nucleus.
Sensors
Radars, sonars, cameras, temperature, etc. Multitude of surface and internal receptors.
Maneuverability
Size
Smaller than conventional aircraft. No space considerations necessary for human 
operator.
Diameter 2–4 µm. Small size possible because of the lack of a nucleus, which spans at 
least 5 µm.
Access
Provides wide coverage over large areas. Small size provides access to spaces not 
available to conventional aircraft.
Full coverage of the vascular system. Upon activation, chemotaxis and transmigration 
has been proposed.f Small size permits rapid access to even the narrowest capillaries.
Expendability
Cost-effectiveness
Significant cost and space savings when human operator is left out of its design (e.g., 
oxygen tanks, cockpits, canopy, interfaces, temperature controls), resulting in higher 
payload–to–dead weight ratios.
Does not require space or other resources otherwise dedicated for maintaining the 
nucleus (e.g., nucleotides, phospholipids, nuclear transporters, DNA repair enzymes).
Production
Higher maximum production rate than with conventional aircraft. Can be mass-produced 
on factory lines.
Large quantities of platelets can be mass-produced by megakaryocytes.g Benefits from 
economy of scale.
Payloads
Carries lethal or nonlethal payloads. Carries molecules with cytotoxic, proinflammatory, or thrombotic functions that may 
harm both pathogens and tissues as well as nontoxic bioactive mediators that 
mediate other functions, such as intercellular communication.
Functions (during conflicts)
Surveillance and reconnaissance, weapon strikes, delivery of ammunition and supplies. Detection of pathogens/breached vasculature and signaling for leukocyte activation 
and/or recruitment; direct pathogen killing/thrombosis; delivery of support 
proinflammatory/thrombotic factors, as well as angiogenic and growth factors.
aDictionary of Military and Associated Terms, US Department of Defense, 2005.
bReflects design concerns.
cThe American Heritage Medical Dictionary, © 2007, 2004 by Houghton Mifflin Company.
dMedical definitions tend to reflect the historical bias of the platelet’s hemostatic function.
eDefining trait of UAV versus conventional aircraft.
fPitchford, S.C., S. Momi, S. Baglioni, L. Casali, S. Giannini, R. Rossi, C.P. Page, and P. Gresele. 2008. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am. J. Respir. 
Crit. Care. Med. 177:604–612.
gEstimated at 2,000–4,000 platelets per megakaryocyte.
Platelets as drones | Li et al.2196
of the entire vascular system at any given point in time. Com-
bined with their expendability, platelets possess all the charac-
teristics to act as the ideal surveillance automatons. Indeed, for 
such a small package, platelets contain a surprisingly large 
array of detectors for monitoring threats, augmented by their 
large OCS surfaces available for environmental interaction. To 
give readers a sense of the receptors present on platelets, a 
nonexhaustive list of the types of known receptors is pre-
sented in Fig. 1, and their associated ligands are additionally 
described in Table S1. Because we are not able to fully explore 
this exciting topic in full detail, we instead refer readers to 
excellent and dedicated reviews on platelet receptors cited 
here (Clemetson and Clemetson, 2013; Saboor et al., 2013; 
Cognasse et al., 2015).
Hemostatic sensing. For detecting breaches of vascular in-
tegrity, platelets express several cell surface receptors that 
not only perform cell signaling but often double as adhesion 
molecules. Normally, the luminal walls of the blood vessels 
are coated by protective glycocalyx layers that prevent plate-
lets from coming into direct contact with the endothelium 
or the basal layers. Any exposure to the structural compo-
nents of the basal layers would signify that a breach has oc-
curred and thus trigger platelet activation and clot formation 
to physically seal the gaps. For this purpose, platelets express 
several receptors that can detect these as well as other com-
ponents of the coagulation cascade. For example, platelet 
integrin α2β1 (GPIa-IIa, CD49b/CD29) can bind collagen, 
while activated αIIbβ3 (GPIIb-IIIa, CD41/CD61) binds fi-
brinogen. Other activation receptors may also detect soluble 
markers of damage, the most important being the puriner-
gic receptors P2X1, P2Y1, and P2Y12, which detect ADP 
and ATP released from damaged cells (Eltzschig et al., 2012).
It is increasingly being appreciated that platelets inte-
grate biophysical cues from the environment. For example, 
platelets may adjust their activation and apoptotic status based 
Figure 1. Platelet receptors. List of receptors in human platelets categorized by their major functional types. The areas of circles correspond proportion-
ally to the number of members shown here. The major involvement of each molecule in hemostasis, immunity, or both is color-coded. Receptors of unclear 
contributions to hemostasis or immunity are shown in gray. Examples of the corresponding ligands of these receptors are listed in Table S1.
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on their mechanosensing of the stiffness of the underlying 
matrix (Qiu et al., 2014; Kee et al., 2015). Conversely, they 
may also adjust their membrane stiffness in response to their 
activation status (Nguyen et al., 2016). Platelets can addition-
ally sense shear flow rates such that diminishing shear rates 
can signal the appropriate timing to undergo clot retraction 
(Muthard and Diamond, 2012). GPIb-IX, the major platelet 
receptor for the von Willebrand factor (VWF), has been im-
plicated as a major receptor for the mechanotransduction of 
shear forces (Deng et al., 2016; Ju et al., 2016).
Although the exact mechanisms remain unclear, it also 
appears that platelets can respond to changes in temperature. 
For example, in vitro experiments indicated that platelet 
exposure to elevated temperatures (>42°C) could increase 
platelet aggregation responses to ADP, and the effect per-
sisted even after cooling to normal body temperature (Gader 
et al., 1990). In the opposite example, platelet exposure to 
brief periods of low temperatures (0–4°C) can induce the 
“cold storage lesion” phenomenon. The phenomenon is so 
termed because it was discovered early on that platelets iso-
lated from blood donors underwent shape changes and had 
drastically reduced life spans from 8 to 3 days in transfusion 
recipients, if they were stored by refrigeration, compared with 
those kept at room temperature (Rumjantseva and Hoffmeis-
ter, 2010), even though the platelets were warmed up to body 
temperature before transfusion. Therefore, counterintuitively, 
many current hospital guidelines recommend room tempera-
ture storage of platelet products despite the increased risk of 
bacterial growth. An explanation for this phenomenon is that 
the exposure of platelets to low temperatures leads to the ir-
reversible clustering of surface GPIb receptors, resulting in 
the recognition of clustered β-N-acetylglucosamine residues 
by β2 integrins on hepatic Kupffer cells. During extended 
cold storage, desialylation further leads to the exposure of 
galactose residues, which are recognized by Ashwell-Morrell 
receptors of hepatocytes that also perform platelet clearance 
(Rumjantseva et al., 2009). In any case, platelets appear re-
sponsive to temperature fluctuations, and although both of 
the phenomena described here were demonstrated with 
nonphysiological extremes, it is tempting to speculate that 
they represent in-built mechanisms for the promotion or 
prevention of thrombosis.
Immune sensing. Previously, the prevailing view was that 
platelets had few, if any, roles in immunity. This started chang-
ing, however, when it became apparent that platelets express a 
plethora of immune-related receptors and ligands (Morrell et 
al., 2014). About two decades ago, CD40L (CD154), an im-
portant ligand used by T cells to activate B cells, was one of 
the earliest such “purely immune” markers to be discovered 
on platelets (Henn et al., 1998; Blumberg et al., 2009). Since 
then, many other molecules present on platelets were also 
discovered to play important roles in immunity, including in-
tegrins and their ligands, P-selectin, Toll-like receptors (e.g., 
TLR4), scavenger receptors, Siglecs, complement receptors, 
and immunoglobulin receptors such as FcεRI and FcγRIIa in 
human (but not mice) platelets, among others.
Platelet payload
Major modes of storage. Platelets compartmentalize their 
payloads (Fig. 2) into a few main types of secretory pack-
ages, namely, the α granules, dense granules, and lysosomes 
(Blair and Flaumenhaft, 2009). They can also deliver cargo 
via platelet microparticles (Hargett and Bauer, 2013). Plate-
let secretory contents include not only those that are pre-
synthesized by megakaryocytes and stored in granules, such 
as PF4, but also those that may be synthesized de novo from 
preexisting mRNA, as in the case of IL-1b. In addition, 
platelets also actively undergo receptor-mediated endocyto-
sis to incorporate and concentrate certain proteins from the 
blood plasma into their granules, as reported for fibrinogen, 
which is sequestered using αIIbβ3. Proteomic studies have es-
timated that platelet releasates contain at least 300 distinct 
mediators (Pagel et al., 2017), while genomic analyses of the 
platelets identified approximately 9,500 mRNA reads with 
known protein-coding loci (Rowley et al., 2011; Bray et al., 
2013; Schubert et al., 2014), not inclusive of numer-
ous noncoding RNA types.
The platelet arsenal. α granules are the most abundant type, 
with 50–80 per platelet, accounting for 10% of the platelet 
volume, 10 times more than the dense granules (Blair and 
Flaumenhaft, 2009). α granules contain most of the protein 
mediators and are endowed with diverse roles, such as clotting 
factors (e.g., factor V, VWF, fibrinogen), chemokines (e.g., PF4, 
CXCL7), and adhesion molecules (e.g., P-selectin, αIIbβ3). 
When stimulated, the α granules fuse with the nearby mem-
branes of the OCS, releasing their soluble contents to the 
plasma while translocating membrane-spanning proteins, 
such as P-selectin, to the platelet surface. It is estimated that 
more than half of a platelet’s total αIIbβ3 is stored within α 
granules and displayed only when activated. The α granule 
membranes occupy almost as much area as the OCS, and thus 
when stimulated, the fused membranes may increase platelets’ 
surface area by up to fourfold. Dense granules (three to eight 
per platelet), on the other hand, contain mostly small mole-
cules such as ADP, serotonin, epinephrine, histamine, and 
ionic calcium bound by acidic polyphosphates, while lyso-
somes contain mainly proteases such as cathepsins.
From the functional point of view, platelets can thus 
potentially secrete a very large repertoire of active media-
tors. These include those potentially lethal to pathogens such 
as the antimicrobial factors PF4 and CCL5, and proteases 
such as elastase. They can also secrete nonlethal mediators, 
such as platelet activators (e.g., ADP), endothelial modulators 
(e.g., nitric oxide, histamine), cytokines, chemokines, growth 
factors, and clotting factors. Granules also contain factors 
such as adhesion molecules and cell surface receptors that 
get transferred to the cell surface upon membrane fusion. 
By releasing these factors or expressing different adhesion 
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receptors, platelets are able to interact with different cell 
types and activate them.
In addition to these “traditional” mediators, platelets 
may also modulate the cellular activity of other cell types by 
the unconventional transfer of its RNA load via microparti-
cles (Risitano et al., 2012; Laffont et al., 2013). Microparticles 
are small (0.1–1 µm) fragments of cellular plasma membranes, 
also produced by many other cell types, but are mostly plate-
let derived (90%; Italiano et al., 2010). They can transfer vari-
ous peptides, lipids, RNA, and DNA from one cell to another 
without direct cell-to-cell contact (Barteneva et al., 2013). 
The RNA content in platelets consist not only of mRNA 
but also many other types of noncoding RNA, such as mi-
cro-RNA and viral-like repeat elements (Bray et al., 2013; 
Provost, 2017). The exact roles of these platelet microparticles 
remain currently unclear.
The vast array of bioactive mediators stored in plate-
lets argue that these anucleated cells are in fact optimally 
equipped to sense, make decisions, and deploy an arsenal 
of molecules in response to environmental demands. Thus, 
platelets are remarkably autonomous despite their reduced 
size and inability to mount complex transcriptional responses.
Platelet programming (functions)
Coordination of sensor input and payload delivery. Akin to 
UAVs, sensor input must be integrated with their responses 
to generate effective and meaningful outcomes. Given their 
wide array of multifunctional receptors and payloads, both 
“lethal” (i.e., cytotoxic, thrombotic, or proinflammatory) 
and “nonlethal,” platelets must carefully regulate their re-
sponses or risk inadvertent thrombosis or tissue damage. A 
complex regulatory mechanism, via purinergic signaling by 
CD39 that converts inflammatory ATP or ADP to AMP, and 
CD73 that converts AMP to anti-inflammatory adenosine, 
may regulate the extent of platelet activation (Eltzschig et 
al., 2012; Antonioli et al., 2013). It is also likely that the 
abundant and unique noncoding RNA in platelets may 
somehow coordinate these processes (Provost, 2017). Other 
undiscovered mechanisms of signal transduction and inte-
gration likely exist. For example, platelets appear to distin-
guish between different types of bacterial LPS, resulting in 
different secretion responses, even though signaling occurs 
through the same receptors (Berthet et al., 2012).
Intriguingly, platelet granules contain payloads with par-
adoxical and mutually antagonistic functions. This is promi-
nent in α granules, which simultaneously contain coagulants 
and anticoagulants, angiogenic and antiangiogenic factors, 
proteases and protease inhibitors, and proinflammatory and 
anti-inflammatory mediators (Fitch-Tewfik and Flaumen-
haft, 2013). Given this observation, it is a mystery as to how 
platelets accomplish their intended effects. An attractive ex-
planation would be the existence of granule subsets organized 
Figure 2. Platelet payloads. List of bioactive mediators released by human platelets categorized by their major functional roles. Many of these mediators 
play multiple roles but are categorized only once. CXCL7 is unique among chemokines in that it is cleaved into multiple distinct peptides with varying functions.
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by functional themes. Indeed, it was observed that VWF and 
fibrinogen were packaged differentially (Sehgal and Storrie, 
2007). However, mapping of the various cargo contents by 
superresolution microscopy suggested otherwise, as the al-
location of the cargo types to individual granules appeared 
stochastic and nonthematic (Kamykowski et al., 2011). Yet 
within each granule, individual cargo was observed to spa-
tially segregate into zones, affording the possibility of partial 
release that is somehow controlled at the subgranule level. 
Interesting hypotheses have been put forward that await con-
firmation (Heijnen and van der Sluijs, 2015).
Hemostatic surveillance and support programs. Platelets are 
responsible for the maintenance of the blood vessel walls (i.e., 
hemostasis; Fig. 3). This statement may seem obvious in light 
of their well-known role in thrombosis, but what may be less 
appreciated is that they also reinforce vessel resistance to leak-
age through other mechanisms to support endothelial func-
tion (Ho-Tin-Noé et al., 2011). For example, depletion of 
platelets resulted in the ultrastructural thinning of blood ves-
sel endothelia detectable from as early as 6 h onward, but this 
effect was reversed by platelet replenishment (Haselton and 
Alexander, 1992), highlighting their role in maintaining the 
integrity of the resting, intact endothelium. After the occur-
rence of a thrombotic event, platelets are also additionally in-
volved in the support of multiple processes that restore vessel 
integrity, including wound healing, angiogenesis, and remod-
eling (Golebiewska and Poole, 2015).
Depending on the circumstances, however, platelets 
can also achieve the reverse. In the presence of a hemostatic 
insult, one might imagine that a tight endothelial seal may 
be beneficial to reduce fluid loss. However, if the insult is 
of an immune nature, a tight endothelium would instead 
impede the timely recruitment of leukocytes to the tissue. 
Figure 3. Major platelet tasks in hemostasis and immunity. Platelets circulate in blood, surveying the vasculature for (A) hemostatic and (B) immune 
threats. (A) Platelets detect vascular breaches using a variety of receptors, such as those binding exposed collagen (1). They respond to danger signals such 
as ADP or the contents of Weibel-Palade (WP) bodies, released by damaged or activated endothelial cells (2). Upon activation, platelets can initiate thrombo-
sis (3) while regulating vessel permeability (4). They also act as gatekeepers, physically preventing erythrocyte loss during leukocyte transmigration (5), and 
also at the lymphovenous junction at steady state or during lymphangiogenesis (6). (B) Platelets may recognize immune threats directly using evolutionarily 
conserved pattern receptors (1) or indirectly via leukocyte signals, such as neutrophil extracellular traps (NETs) or cytokines (2). Platelets can bind and wrap 
around pathogens, triggering degranulation to effect killing (3) and direct/indirect leukocyte recruitment (4). Additionally, platelets often physically interact 
with leukocytes to deliver or exchange signals that result in fully active inflammation, for example by taking up arachidonic acid (AA) from neutrophils to 
synthesize thromboxane A2 (TXA2; 5).
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Many pathogens have evolved mechanisms that can subvert 
the immune system (Wilson et al., 2002; e.g., toxin release), 
and the amount of time that the pathogen is left unchallenged 
to mount these defenses can determine the outcome of an in-
vasion. Proinflammatory mediators found in platelet granules 
thus aid leukocyte transmigration as well as enhance delivery 
of their antipathogenic payload to the tissues by selectively 
increasing vessel permeability. Indeed, platelet serotonin was 
responsible for increasing vessel permeability in immune 
complex–mediated inflammation (Cloutier et al., 2012). Par-
adoxically, in these cases, even though platelets may promote 
vascular permeability, they are also simultaneously required 
to seal the vascular breaches after leukocyte transmigration; 
otherwise they risk the loss of erythrocytes into the tissues 
(Gros et al., 2015). During vessel damage and subsequent 
thrombosis, the entry of plasma proteins into tissues persist 
for extended durations even after clot formation that halts 
erythrocyte losses (Welsh et al., 2016). Thus, holistically, plate-
lets are not purely hemostatic, as they preserve tissue integrity 
through mechanisms that do not always support the integrity 
of the endothelial barrier.
Surprisingly, platelets are also responsible for the de-
velopment and maintenance of the lymphatic vessels, even 
though their presence there is generally undetected. Plate-
lets use the C-type lectin receptor CLEC-2 to interact with 
lymphatic vessels via binding podoplanin. During embryonic 
development, this interaction is critical for maintaining the 
separation of blood and lymph vessels (Osada et al., 2012). 
This is true even in adults, as perturbation of this interaction 
results in the backflow of blood into the lymphatic network. 
Interestingly, platelet thrombi formation was necessary to 
perform a gatekeeping role at the lymphovenous junction of 
the thoracic duct (Hess et al., 2014). A similar process pre-
serves the integrity of lymph nodes, which are constitutively 
infiltrated by lymphocytes, by regulating the expression of 
vascular endothelial cadherin and sealing off the lymph node 
vasculature (Herzog et al., 2013). Although podoplanin is 
normally associated only with lymphatic endothelia, it was 
recently discovered that venular blood vessels may also grad-
ually express podoplanin under stenosis-mediated hypoxia 
(which mimics deep vein thrombosis in humans), resulting 
in CLEC-2–mediated platelet activation (Payne et al., 2017). 
Hence, this may represent the default on-site thrombosis 
mechanism in the absence of direct blood loss.
Immune surveillance and support programs. Platelets may in-
teract directly with their targets and perform its killing func-
tion. For example, platelets may bind and wrap bacteria 
(Youssefian et al., 2002) or induce their aggregation (O’Brien 
et al., 2002), leading to degranulation. During malaria infec-
tion, platelets have also been described to perform the direct 
killing of plasmodium parasites in their blood stage forms in a 
PF4-dependent manner (McMorran et al., 2009, 2012), lead-
ing to the general perception that platelets play protective 
roles during an infection. However, a recent in vivo study in 
mice paradoxically found that platelet depletion did not lead 
to higher parasitemia levels (Gramaglia et al., 2017). Instead, 
links were found between the presence of platelets and malar-
ial pathogenesis via CD40 interactions. Because about two 
thirds (Jadhav et al., 2004) of malarial infections are accompa-
nied by thrombocytopenia, it thus remains a quandary for 
clinicians to decide if they should be boosting or inhibiting 
platelet function in these patients.
A recurrent observation in immunity and inflammation 
is that platelets do not act in isolation. They may activate in 
response to pathogens already marked for destruction by op-
sonins (e.g., complement or immunoglobulins) from other 
cell types. Vascular endothelial cells may also signal for their 
help by expressing activated forms of adhesion molecules or 
ligands and by enzymatic thinning of their glycocalyx. In some 
organs, such as the lung, both endothelial cells and leukocytes 
can directly signal platelet activation through ADP production 
via CD39 activity (Antonioli et al., 2013). Conversely, platelet 
granules contain cytokines and chemokines that can activate 
and recruit leukocytes to the site of activation, and platelets 
bound to the vascular wall additionally present P-selectin to 
support leukocyte capture (Schmidtke and Diamond, 2000).
A unique and notable feature of platelets is their ten-
dency to form physical aggregates with other leukocytes, in-
cluding lymphocytes (Li et al., 2006), dendritic cells (Czapiga 
et al., 2004), monocytes (Sarma et al., 2002), eosinophils 
(Pitchford et al., 2005), basophils (Liso and Bonomo, 1982), 
and neutrophils (Mauler et al., 2016). P-selectin (CD62P) on 
platelets and PSGL-1 (CD162) on leukocytes are thought to 
be the most important interaction providing the adhesion (de 
Bruijne-Admiraal et al., 1992). Additionally, CD40/CD40L 
interactions and integrin αMβ2 (Mac-1, CD11b/CD18, CR3) 
interactions (for myeloid cells) also appear important. Aggre-
gate formation may be a secondary outcome of the various 
cell-cell physical interactions between platelets and leuko-
cytes, as this would leave the platelets “stuck” on the leuko-
cytes for an extended period of time. Although the existence 
of these leukocyte-platelet aggregates has long been known, 
its biological significance is only beginning to emerge. Cir-
culating platelet-leukocyte aggregates are increased in sepsis 
patients, but those that develop multiple-organ failure actually 
display decreased numbers, likely because of enhanced pe-
ripheral sequestration (Gawaz et al., 1995).
Several examples illustrate the diverse support roles that 
platelets play on immune cells. In the lymph node, platelets 
were shown to help guide lymphocytes into the high en-
dothelial venules by bridging their interactions (Diacovo et 
al., 1996), whereas platelets could deliver co-stimulatory sig-
nals to immature dendritic cells (Czapiga et al., 2004). In the 
case of the myeloid cells, platelet binding typically leads to 
the proinflammatory activation of the leukocyte, for exam-
ple, in monocytes (Passacquale et al., 2011) and eosinophils 
(Pitchford et al., 2005). The significance of platelet binding 
to basophils (Liso and Bonomo, 1982) has not been well 
studied, but interestingly, mouse basophils also express the 
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fibrinogen receptor αIIbβ3, being the only mature leukocyte 
to do so, and they up-regulate this integrin upon activation 
(Bakocevic et al., 2014).
The functional relationships between platelets and 
neutrophils have been more extensively studied. Platelet- 
neutrophil complexes occur in many acute and chronic in-
flammatory diseases (Mauler et al., 2016), and disruption of 
their formation by antibody blockade greatly reduces the se-
verity of acute inflammation (Zarbock et al., 2006). Upon 
immune activation, neutrophils polarize and extrude their 
PSGL-1-containing uropods into the vascular lumen, which 
allows active scanning of activated platelets in the blood-
stream (Sreeramkumar et al., 2014). Notably, this interplay 
is important for full neutrophil activation and inflammatory 
reactions, because mice in which neutrophils are unable to 
polarize or to transduce PSGL-1 signaling display aberrant 
crawling on the vasculature and are protected from inflam-
matory injury (Sreeramkumar et al., 2014). In the context 
of an infection, platelet interactions with neutrophils are ini-
tially mediated by P-selectin and PSGL-1, and subsequently 
interactions with platelet-borne GPIb induce neutrophils 
to secrete extracellular vesicles containing arachidonic acid, 
which are taken up by platelets. Platelet cyclooxygenase-1 
(COX-1) can then use this lipid as a substrate to synthesize 
thromboxane A2, ultimately eliciting an inflammatory re-
sponse needed to clear the infectious agent (Rossaint et al., 
2016). Other studies have further described roles for CD40/
CD40L interactions (Zuchtriegel et al., 2016) downstream 
of P-selectin. Thus, nucleated neutrophils appear to rely on 
anucleated platelets for both instruction and support to fully 
achieve its own activation status. In these scenarios, platelets 
first use their own receptors to sense danger and then transmit 
the information to neutrophils. This is best illustrated in the 
context of sepsis, in which endotoxin-activated platelets bind 
neutrophils and induce the formation of neutrophil extracel-
lular traps (NETs), which consist of unpacked extracellular 
genomic DNA coated with histones and other antimicrobial 
peptides that form net-like structures within vessels that trap 
and facilitate bacterial elimination (Clark et al., 2007). Neu-
trophils have to integrate integrin-mediated outside-in and 
G-protein coupled receptor signaling to induce NET for-
mation (Rossaint et al., 2014). On the other hand, NETs can 
also capture circulating platelets and cause the release of poly-
phosphates and thrombin, resulting in the polymerization of 
fibrin threads (McDonald et al., 2017), ultimately triggering 
thrombosis (Fuchs et al., 2010).
Other modalities of platelet-leukocyte cooperation have 
been described. Under conditions of inflammation, small pro-
teins released by both neutrophils and platelets can heterom-
erize to elicit responses on a third cell type, such as monocytes 
(Alard et al., 2015). This type of mechanism may account for 
the causative role of platelet activation during atherosclerosis, 
during which release of platelet-borne chemokines onto the 
vasculature or leukocyte surfaces drive monocyte accumulation 
on atherosclerotic plaques (Huo et al., 2003). Somewhat contra-
dictorily, a recent study suggests that platelets are also involved 
in the resolution phase of inflammation (Slaba et al., 2015). 
Overall, these studies suggest that although platelets do func-
tion as classical hemostatic effectors, their large numbers, small 
size, and vast array of sensors and bioactive molecules enable 
surveillance of all irrigated tissues, integration of environmental 
signals, and instruction of leukocyte responses, even when the 
immune cells are far from the source of danger (Fig. 3).
Concluding remarks
Platelets appear uniquely designed to function without nuclei, 
foregoing a measure of autonomy, in exchange for substan-
tial advantages in maneuverability and expendability. Despite 
this, the importance and complexity of platelets do not seem 
to be diminished. Abundantly filled with sensors and pay-
loads, platelets efficiently survey every nook and cranny of 
the mammalian vasculature. This, in turn, allows efficient co-
ordination with multiple cell types, from endothelial cells to 
leukocytes, to participate in many direct and support roles in 
hemostasis and immunity (Fig. 3). We hope that this review 
will spark a conceptual shift in how platelets are perceived, 
from an inert clot-forming “cell fragment” to an entity that 
displays autonomy, motility, and a remarkable ability to sense 
and respond to environmental challenges. Future research 
will likely expand the paradigms discussed here and surely 
reveal even more surprises in nature’s design for these mam-
malian surveillance drones.
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Table S1. Partial list of human platelet receptors and their ligands
Receptor Example ligands Proposed involvement
Hemostasis Immunity
Pattern recognition receptors
CD36 TSP1, oxidized phospholipids, lipopeptides, lipoproteins, long chain fatty acids x x
NOD2 Muramyl dipeptide x
SRB1 Phospholipids, cholesterol ester, lipoproteins, phosphatidylserine x x
TLR1 (CD281) Lipopeptides x
TLR2 (CD282) Glycolipids, lipoproteins, HSP70, zymosan, lipotechoic acid x
TLR3 (CD283) dsRNA, poly I:C x
TLR4 (CD284) LPS, heat shock proteins, HMGB1, fibrinogen, heparan sulfate fragments, hyaluronic 
acid fragments, nickel
x
TLR6 (CD286) Lipopeptides x
TLR7 ssRNA x
TLR9 (CD289) Unmethylated CpG x
Antigen receptors/presentation/
co-stimulation/complement receptors
CD40L (CD154) CD40 x
C1qRp (CD93) C1q? (exact ligands unclear) x
C3aR C3a x
C5aR (CD88) C5a x
FcαRI (CD89) IgA x
FcεRI (CD23) IgE x
FcγRIIa (CD32) IgG x
MHC class I CD4 x
Chemokine receptors
CCR1 (CD191) CCL3, CCL5, CCL7, CCL15 x
CCR3 (CD193) CCL5, CCL7, CCL11, CCL13, CCL26 x
CCR4 (CD194) CCL2, CCL3, CCL4, CCL5, CCL17 x
CXCR4 (CD184) CXCL12 x
CX3CR1 CX3CL1 x
Sialic acid-binding receptors
Siglec-7 α2,8-linkage, α2,6-linkage, α2,3-linkage x
Siglec-9 α2,3-linkage, α2,6-linkage x
Siglec-11 α2,8-linkage x
Adhesion molecules and ligands
α2β1/GPIa-IIa/VLA-2 (CD49b/CD29) Collagen x
α2bβ3/GPIIb-IIIa (CD41/CD61) Fibrinogen, fibrin, VWF, fibronectin, vitronectin, thrombospondin x
α5β1/VLA-5 (CD49e/CD29) Fibronectin x
α6β1/VLA-6 (CD49f/CD29) Laminin x
αVβ3 (CD51/CD61) Vitronectin, fibronectin, VWF, prothrombin, thrombospondin, osteopontin x
GPIb-IX-V (CD42) VWF, P-selectin, αMβ2, factor XII, XI, thrombin, C3 x
ICAM-2 (CD102) αLβ2/LFA-1 (CD11a/CD18) x
JAM-C/JAM-3 FcγRIIa, αMβ2/Mac-1 (CD11b/CD18) x x
P-selectin (CD62P) PSGL-1, GPIb, tissue factor, C3b x x
PEC AM-1 (CD31) PEC AM-1, collagen, glycosaminoglycans, αVβ3 x x
Thrombosis-regulatory receptors
CLEC-2 Podoplanin, rhodocytin x




SLAM/SLA MF1 (CD150) Other SLAM family members, measles virus, OmpC, OmpF x x
SLA MF5 (CD84) SLAM family members x
TLT-1 FcεRI? (physiological ligands unclear) x x
Purinergic and eicosanoid receptors
A2a (P1 type) Adenosine x x
P2X1 ATP x x
P2Y1 ADP x x
P2Y12 ADP x x
EP3 PGE2 x x
IP PGI2 x ?
TP TXA2, PGH2 x x
S15JEM 
Receptor Example ligands Proposed involvement
Hemostasis Immunity
Hormone and metabolic receptors
5-HT2A Serotonin x x
Arginine vasopressin receptors Vasopressin x ?
c-mpl (CD110) Thrombopoietin ? ?
Dopamine receptors Dopamine ? ?
Insulin receptor (CD220) Insulin ? ?
Leptin receptor (CD295) Leptin ? ?
PDGF-Rα PDGF ? ?
Platelet-activating factor receptor Oxidized LDL, PAF ? x
Tie-1 Angiopoietin ? ?
β2 adrenergic receptor Epinephrine x ?
Table S1. Partial list of human platelet receptors and their ligands (Continued)
